DK1007566T3 - Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf - Google Patents
Terapeutisk anvendelse af SMR1-protein og aktive derivater derafInfo
- Publication number
- DK1007566T3 DK1007566T3 DK98912339T DK98912339T DK1007566T3 DK 1007566 T3 DK1007566 T3 DK 1007566T3 DK 98912339 T DK98912339 T DK 98912339T DK 98912339 T DK98912339 T DK 98912339T DK 1007566 T3 DK1007566 T3 DK 1007566T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapeutic
- well
- molecules
- present
- preventing
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 5
- 101710082215 SMR1 protein Proteins 0.000 title 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 239000011707 mineral Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108090000244 Rat Proteins Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000003298 dental enamel Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000001156 gastric mucosa Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000000762 glandular Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 230000035800 maturation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 210000000496 pancreas Anatomy 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/854—Glands
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/801,405 US6589750B2 (en) | 1997-02-20 | 1997-02-20 | Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1007566T3 true DK1007566T3 (da) | 2007-01-02 |
Family
ID=25181003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98912339T DK1007566T3 (da) | 1997-02-20 | 1998-02-19 | Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf |
Country Status (10)
Country | Link |
---|---|
US (4) | US6589750B2 (de) |
EP (2) | EP1702929A3 (de) |
AT (1) | ATE337339T1 (de) |
AU (1) | AU6721998A (de) |
CA (1) | CA2281912A1 (de) |
DE (1) | DE69835680T2 (de) |
DK (1) | DK1007566T3 (de) |
ES (1) | ES2271991T3 (de) |
PT (1) | PT1007566E (de) |
WO (1) | WO1998037100A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6589750B2 (en) * | 1997-02-20 | 2003-07-08 | Institut Pasteur | Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives |
ATE291927T1 (de) | 1999-06-23 | 2005-04-15 | Pasteur Institut | Peptide zur behandlung von beeinträchtigten zwischenmenschlischen störungen und verhaltenstörungen |
PT1216707E (pt) * | 2000-12-22 | 2005-06-30 | Pasteur Institut | Novas utilizacoes terapeuticas para um smr-1-peptideo |
MXPA05008097A (es) | 2003-01-28 | 2006-02-08 | Microbia Inc | Metodos y composiciones para el tratamiento de desordenes gastrointestinales. |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
DK1577320T3 (da) | 2004-03-19 | 2012-10-15 | Pasteur Institut | Peptider afledt fra humant BPLP-protein, polynukleotider kodende for nævnte peptider og antistoffer rettet mod nævnte peptider |
DE102004026744A1 (de) * | 2004-05-28 | 2005-12-29 | Philipps-Universität Marburg | Erfindung betreffend cDNA-Herstellung aus Zellen nach Laser-Mikrodissektion |
EP2527360B1 (de) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
US8889827B2 (en) | 2008-04-07 | 2014-11-18 | Institut Pasteur | Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases |
FR2931362B1 (fr) * | 2008-05-26 | 2017-08-18 | Pasteur Institut | L'opiorphine pour une utilisation en tant que psychostimulant. |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
US20100221329A1 (en) | 2008-12-03 | 2010-09-02 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase c agonists and methods of use |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
AU2012223337C1 (en) | 2011-03-01 | 2016-11-10 | Bausch Health Ireland Limited | Process of preparing guanylate cyclase C agonists |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
CN109212006A (zh) * | 2018-08-24 | 2019-01-15 | 北京艾普希隆生物科技有限公司 | 一种单细胞琼脂糖凝胶电泳试剂盒 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3374170D1 (en) | 1982-05-06 | 1987-12-03 | Massachusetts Inst Technology | Production of enterovirus neutralizing antibodies from vp1 |
US4699877A (en) | 1982-11-04 | 1987-10-13 | The Regents Of The University Of California | Methods and compositions for detecting human tumors |
GB8327966D0 (en) | 1983-10-19 | 1983-11-23 | Nyegaard & Co As | Chemical compounds |
IL78444A (en) * | 1986-04-08 | 1992-05-25 | Yeda Res & Dev | Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody |
FR2637600B1 (fr) * | 1988-10-11 | 1992-03-06 | Pasteur Institut | Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques |
US5219548A (en) * | 1990-10-01 | 1993-06-15 | Board Of Regents, The University Of Texas System | High affinity halogenated-tamoxifen derivatives and uses thereof |
CA2164966A1 (en) * | 1993-06-23 | 1995-01-05 | Wolfgang Sadee | Compositions and methods for anti-addictive narcotic analgesis activity screening and treatments |
US6589750B2 (en) * | 1997-02-20 | 2003-07-08 | Institut Pasteur | Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives |
ATE291927T1 (de) * | 1999-06-23 | 2005-04-15 | Pasteur Institut | Peptide zur behandlung von beeinträchtigten zwischenmenschlischen störungen und verhaltenstörungen |
PT1216707E (pt) * | 2000-12-22 | 2005-06-30 | Pasteur Institut | Novas utilizacoes terapeuticas para um smr-1-peptideo |
-
1997
- 1997-02-20 US US08/801,405 patent/US6589750B2/en not_active Expired - Lifetime
-
1998
- 1998-02-19 ES ES98912339T patent/ES2271991T3/es not_active Expired - Lifetime
- 1998-02-19 US US09/367,703 patent/US6818405B2/en not_active Expired - Fee Related
- 1998-02-19 WO PCT/EP1998/000956 patent/WO1998037100A2/en active IP Right Grant
- 1998-02-19 EP EP06009596A patent/EP1702929A3/de not_active Withdrawn
- 1998-02-19 AU AU67219/98A patent/AU6721998A/en not_active Abandoned
- 1998-02-19 CA CA002281912A patent/CA2281912A1/en not_active Abandoned
- 1998-02-19 DE DE69835680T patent/DE69835680T2/de not_active Expired - Lifetime
- 1998-02-19 EP EP98912339A patent/EP1007566B1/de not_active Expired - Lifetime
- 1998-02-19 AT AT98912339T patent/ATE337339T1/de active
- 1998-02-19 PT PT98912339T patent/PT1007566E/pt unknown
- 1998-02-19 DK DK98912339T patent/DK1007566T3/da active
-
2003
- 2003-05-12 US US10/435,564 patent/US20030195155A1/en not_active Abandoned
- 2003-07-17 US US10/620,462 patent/US7429448B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1007566B1 (de) | 2006-08-23 |
US20040047805A1 (en) | 2004-03-11 |
DE69835680T2 (de) | 2007-08-23 |
US20020019008A1 (en) | 2002-02-14 |
ES2271991T3 (es) | 2007-04-16 |
DE69835680D1 (de) | 2006-10-05 |
EP1702929A3 (de) | 2007-05-23 |
US20030195155A1 (en) | 2003-10-16 |
US20020198361A1 (en) | 2002-12-26 |
CA2281912A1 (en) | 1998-08-27 |
ATE337339T1 (de) | 2006-09-15 |
AU6721998A (en) | 1998-09-09 |
EP1702929A2 (de) | 2006-09-20 |
US7429448B2 (en) | 2008-09-30 |
PT1007566E (pt) | 2007-01-31 |
WO1998037100A2 (en) | 1998-08-27 |
US6589750B2 (en) | 2003-07-08 |
WO1998037100A3 (en) | 1999-01-07 |
US6818405B2 (en) | 2004-11-16 |
EP1007566A2 (de) | 2000-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1007566T3 (da) | Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf | |
EA200200755A1 (ru) | Опосредованная рецептором nogo блокада роста аксонов | |
EA200300845A1 (ru) | Модифицированные антитела и способы применения | |
ATE467425T1 (de) | Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben | |
CY1106723T1 (el) | Ν-τελικα μονοπεγυλιωμενα συζευγματα ανθρωπινης αυξητικης ορμονης, διεργασιες για την παρασκευη τους και μεθοδοι χρησης αυτων | |
AU1922101A (en) | Human fgf-21 gene and gene expression products | |
BR0212897A (pt) | Conjugados de análogos de somatostatina ou bombesina diagnóstica ou terapêutica e usos dos mesmos | |
ATE433959T1 (de) | Analoge von kokain | |
DK0619370T3 (da) | Anvendelse af keratinocytvækstfaktor (KGF) til fremstilling af farmaceutiske sammensætninger | |
PL2157192T3 (pl) | Kompozycje do diagnozowania i terapii chorób związanych z nieprawidłową ekspresją futrin (R-spondin) | |
HK1025793A1 (en) | Hepatitis c receptor protein cd81 | |
DE69727691D1 (de) | Verwendung von keratinocyten-wachstumsfaktor-2 | |
DK1165102T3 (da) | Matrixproteinpræparater til podning i ikke-mineraliseret væv | |
KR100488038B1 (ko) | 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도 | |
WO2002007676A3 (en) | Compounds having affinity for the granulocyte-colony stimulating factor receptor (g-csfr) | |
DE59909356D1 (de) | Pharmazeutische präparation, enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen | |
WO2000026362A3 (de) | Proteine der stomatinfamilie und ihre verwendung als zielproteine für die schmerztherapie | |
FI972121A0 (fi) | Sammansaettningar foer reciprok oekning av immunosupperssanters och interferoners farmaceutiska aktiviteter |